Why Synthetic Biologics Inc. (AMEX: SYN) Should Be On Your Watchlist – Marketing Sentinel
Home  »  Business   »  Why Synthetic Biologics Inc. (AMEX: SYN) Should Be...

Why Synthetic Biologics Inc. (AMEX: SYN) Should Be On Your Watchlist

During the recent session, Synthetic Biologics Inc. (AMEX:SYN)’s traded shares were 3.08 million, with the beta value of the company hitting 1.83. At the last check today, the stock’s price was $0.66, reflecting an intraday loss of -7.97% or -$0.06. The 52-week high for the SYN share is $1.70, that puts it down -157.58 from that peak though still a striking 60.61% gain since the share price plummeted to a 52-week low of $0.26. The company’s market capitalization is $93.35M, and the average intraday trading volume over the past 10 days was 4.86 million shares, and the average trade volume was 6.62 million shares over the past three months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Synthetic Biologics Inc. (SYN) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 2.00. SYN has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.02.

Synthetic Biologics Inc. (AMEX:SYN) trade information

Synthetic Biologics Inc. (SYN) registered a -7.97% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -7.97% in intraday trading to $0.66 this Thursday, 06/10/21, hitting a weekly high. The stock’s 5-day price performance is 25.22%, and it has moved by 38.76% in 30 days. Based on these gigs, the overall price performance for the year is 61.04%. The short interest in Synthetic Biologics Inc. (AMEX:SYN) is 0.78 million shares and it means that shorts have 0.29 day(s) to cover.

The consensus price target of analysts on Wall Street is $1.88, which implies an increase of 64.89% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.25 and $2.50 respectively. As a result, SYN is trading at a discount of -278.79% off the target high and -89.39% off the low.

Synthetic Biologics Inc. (SYN) estimates and forecasts

Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 88.90% this quarter and then jump 85.70% in the quarter after that.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 48.90%. While earnings are projected to return 32.50% in 2021.

SYN Dividends

Synthetic Biologics Inc. is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


Synthetic Biologics Inc. (AMEX:SYN)’s Major holders

Synthetic Biologics Inc. insiders own 1.78% of total outstanding shares while institutional holders control 6.50%, with the float percentage being 6.62%. Blackrock Inc. is the largest shareholder of the company, while 38 institutions own stock in it. As of Mar 30, 2021, the company held over 2.35 million shares (or 1.78% of all shares), a total value of $1.6 million in shares.

The next largest institutional holding, with 2.01 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 1.53% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $1.37 million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Also, the Mutual Funds coming in first place with the largest holdings of Synthetic Biologics Inc. (SYN) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Mar 30, 2021 indicates that Vanguard Extended Market Index Fund owns about 1.95 million shares. This amounts to just over 1.48 percent of the company’s overall shares, with a $1.33 million market value. The same data shows that the other fund manager holds slightly less at 0.69 million, or about 0.52% of the stock, which is worth about $0.47 million.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts



Download free eBook for 



Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.